Skip to main content

My account

Boston Scientific accounts are for healthcare professionals only.

Create an account to access online training and education on EDUCARE, manage your customer profile, and connect with customer support and service teams.

My Boston Scientific account

Access your online applications and manage your customer profile.

Manage my Boston Scientific account

Quick Links

Contact a representative
Online education and training
Order products online
Reimbursement resources
Return a product
Customer support

Call customer care

1 (888) 272-1001

Study led by Dr. Jacqueline Saw, 2022

Procedural simplification of left atrial appendage occlusion using the VersaCross Connect™ system: First in-human experience1

First in-human experience with the exchangeless VersaCross Connect LAAC Access Solution

Eliminate six steps from your WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device procedures, compared to the standard needle-based workflow

Key takeaways

  • Improved WATCHMAN FLX™ LAAC procedural efficiency by eliminating six steps from standard needle-based workflows 
    • Short overall procedure time: 31 minutes (± 6.3)
    • Short interval between left atrial appendage access and device deployment: 12.2 minutes (± 1.9)
  • Fewer sheath exchanges can reduce the risk of air embolism and perforation2
  • LAAC was successful in 100% of patients, with no procedural complications*
Workflow of VersaCross Connect LAAC Access Solution eliminates six steps from the LAAC procedure compared to standard needle-based workflow.

Transseptal reimagined.

Request a sales representative

VersaCross Connect LAAC Access Solution simplifies LAAC procedures by connecting the VersaCross Connect Transseptal Dilator with WATCHMAN Access Sheaths† for zero exchange left heart access

Products in this study

VersaCross Connect LAAC Access Solution.

VersaCross Connect LAAC Access Solution

Explore product details

References:

 

1. Perrin, N., et al. (2022). Procedural simplification of left atrial appendage occlusion using the VersaCross connect system: First in‐human experience. Catheter Cardiovasc Interv, 101(1), 227-230. doi: 10.1002/ccd.30503

2. Deneke, T., et al. (2014). Exchanging Catheters Over a Single Transseptal Sheath During Left Atrial Ablation is Associated with a Higher Risk for Silent Cerebral Events. Indian Pacing Electrophysiol J,14(5):240-249. doi: 10.1016/s0972-6292(16)30795-1.

* Nine consecutive cases of WATCHMAN FLX™ LAAC were performed using the VersaCross Connect LAAC Access Solution. 

† The VersaCross Connect Transseptal Dilator is for use with a 12F ID WATCHMAN™ Access Sheath that is 75 cm in length, specifically: WATCHMAN™ Access System [Models: M635TU40060, M635TU10060, M635TU20060]; WATCHMAN™ TruSeal™ Access System [Models: M635TU70010, M635TU70040, M635TU70020]; WATCHMAN FXD Curve™ Access System [Models: M635TU80010, M635TU80020].

All trademarks are the property of their respective owners.

Indications, safety, and warnings

VersaCross Connect LAAC Access Solution indications, safety, and warnings
WATCHMAN FLX indications, safety, and warnings
WATCHMAN FXD Curve™ Access System indications, safety, and warnings